October 2026
Pharmaceutical Innovation and the Inflation Reduction Act: 2026 Mid-Year Review
We follow 19 biopharma companies that have had or are likely to have a drug selected for Medicare negotiation as a result of the Inflation Reduction Act (IRA) of 2022.



